Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017:
|
|
- Rosalyn Henry
- 5 years ago
- Views:
Transcription
1 Canadian Stroke Best Practice Recommendations STROKE PREVENTION WRITING GROUP 2017: NAME PROFESSIONAL ROLE LOCATION DECLARED CONFLICTS OF INTEREST Wein, Theodore Gladstone, David Côté, Robert Berlingieri, Joseph Co-Chair, Assistant Professor of Neurology and Neurosurgery, McGill University Stroke Prevention Clinic, Montreal General Hospital Associate Professor, Department of Medicine (Neurology), University of Toronto; Director, Regional Stroke Prevention Clinic, Sunnybrook Health Sciences Centre, Toronto Stroke Neurologist, Professor, Department of Neurology, Neurosurgery and Medicine; McGill University Health Centre Internist and Intensivist; Medical Co-Director of JBN Medical Diagnostic Services (private stroke prevention clinic in Burlington, linked to Hamilton stroke program; brings community perspective) Quebec Potential Conflict: BoehringherIngelheim Research, Speaker, Travel Potential Conflict: Bayer Research, Speaker, Travel Potential Conflict: Allergan Inc Research, Consultant, Potential Conflict: Servier Research, Speaker Potential Conflict:Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, Pfizer : speaker fees for CME events and/or honouraria for advisory boards Potential Conflict: EMRACE trial and SCREEN-AF trial Principal Investigator Quebec Pfizer/BMS Speaker honorarium Potential or Actual Conflict of Interest Area of oral anticoagulants Bourgoin, Aline Stroke Prevention Coordinator, Nurse Specialist Stroke Prevention Clinic Champlain Regional Stroke Network, Buck, Brian H. Vascular Neurologist, Assistant Professor, Division of Neurology, Department of Medicine, University of Alberta Alberta : Bayer : Speaker honorarium, advisory board Potential or Actual Conflict of Interest Area of oral anticoagulants CSBPR Sixth Edition Final 25October2017 Page 1 of 6
2 Cox, Jafna Cardiologist; Heart and Stroke Foundation of Endowed Chair in Cardiovascular Outcomes Research Professor of Medicine and of Community Health and Epidemiology, Dalhousie University Potential conflict for the following: Company/OrganizationName Bayer (relationship to until present) Funded research, speaker, advisory board member BoehringerIngelheim (no relationship for 3 years) Speaker, Advisory Board Member BMS Pfizer, no relationship for less than 1 year Speaker, Advisory Board Member Davidson, Dion Vascular Surgeon Valley Regional Hospital Douketis, Jim Internist and Thrombosis Specialist; Divisions of General Internal Medicine, Hematology and Thromboembolism, McMaster University Department of Medicine; President of Thrombosis Canada ( Participant in Advisory Boards or Educational Activities for following companies: Bayer ( ); Bristol- Myers-Squibb ( ); Sanofi ( ); Astra-Zeneca (before 2008); Boehringer-Ingelheim ( ); Pfizer ( ); Biotie (2013); Portola (2012); The Medicines Co. ( ); Daiichi- Sankyo (2015). Consultant to following companies Actelion (2014); AGEN Biomedical ( ); Ortho-Janssen Pharmaceuticals ( ); Boehringer-Ingelheim ( ); Janssen Pharmaceuticals (2014-present); Grant support from following companies: Boehringer-Ingelheim (2014) Falconer, John Internist; UBC Clinical Associate Professor of Medicine; Director Kelowna General Hospital TIA/Stroke Unit; Course Director Foundations of Medicine UBC Southern Medical Program British Columbia Field, Thalia Stroke Neurologist; Assistant Professor, Faculty of Medicine, University of British Columbia Stroke Neurologist, Vancouver Stroke Program British Columbia Potential Conflict: Bayer Canada and Bayer Global : Advisory Board and Speakers' Bureau, research methodology training program participation CSBPR Sixth Edition Final 25October2017 Page 2 of 6
3 Gioia, Laura Stroke Neurologist Assistant Professor Department of Neurosciences, CHUM-Centre Hospitalier de l Université de Montréal Hôpital Notre Dame Potential Conflict: BoehringerIngleheim Funded research Quebec Potential Conflict: Bayer Canada and Bayer Global : Advisory Board Habert, Jeffrey Family Physician, Assistant Professor, University of Toronto, Dept. Of Family And Community Medicine Potential Conflict: Bayer, Bristol-Myers- Squibb, Boehringer-Ingelheim, Pfizer, Eli-Lilly, Astra-Zeneca, Janssen, Novo- Nordisk Jaspers, Sharon Lum, Cheemun Nurse Practitioner, Stroke Prevention Clinic, Thunder Bay Regional Health Sciences Centre Faculty, Northern School of Medicine Neuroradiologist; Section Head, Interventional Neuroradiology, The Ottawa Hospital : Advisory Board/Speaker Potential Conflict: Bayer,BoehringerIngelheim, Pfizer : speaker/workshop: honorarium McNamara Morse, Dana Nurse Practitioner, Stroke Program, Valley Regional Hospital Pageau, Paul Emergency Physician, The Ottawa Hospital Assistant Professor, Department of Emergency Medicine, The University of Ottawa Rafay, Mubeen Paediatric Stroke Neurologist, Winnipeg Children s; University of Manitoba; Paediatric Stroke Writing Group Manitoba Rodgerson, Amanda Clinical Stroke Dietitian Provincial Acute Stroke Unit and Provincial Rehabilitation Unit, Queen Elizabeth Hospital PEI Semchuk, Bill Manager, Clinical Pharmacy, Clinical Pharmacist, Regina Lipid Clinic; Regina Qu Appellle Health Region Saskatchewan Potential Conflict, Paid Speaker for: BoheringerIngelheim, Bayer and BMS Pfizer CSBPR Sixth Edition Final 25October2017 Page 3 of 6
4 Shoamanesh, Ashkan Stroke Neurologist; Assistant Professor of Medicine (Neurology); Director, Stroke Fellowship Program; Marta and Owen Boris Chair in Stroke Research and Care McMaster University / Population Health Research Institute Potential Conflict: Bayer HealthCare Pharmaceuticals Research Stipend for Ongoing Committee Involvement in the NAVIGATE ESUS trial Tamayo, Arturo Stroke Neurologist; Brandon Regional Hospital, Winnipeg Health Sciences Centre; University of Manitoba Manitoba Potential conflict, Speaker for: Bayer, BoehringerIngelheim and Bristol- Myers Squibb CSBPR Sixth Edition Final 25October2017 Page 4 of 6
5 Canadian Stroke Best Practice Recommendations STROKE PREVENTION EXTERNAL REVIEWERS 2017: Secondary Prevention of Stroke CCS 2016 Lipid Guidelines EXTERNAL REVIEWER Dr. Natan Bornstein PROFESSIONAL ROLE Professor of Neurology at the Tel-Aviv University, Sackler Faculty of Medicine Head of Stroke Unit at the Tel-has Aviv Medical Center LOCATION Israel DECLARED CONFLICTS OF INTEREST Pfizer Israel Consultation fees Bayer Israel Consultation fees Company/Organization Boehringer Ingelheim Israel Lecture Bureau Company/Organization Amgen Advisory Board- Honorarium Dr. Seemant Chaturvedi Dr. Marion Cornish Dr. Jamsheed Desai Dr. Robert Hart Professor of Clinical Neurology; Vice Chair Neurology Programs; Miami VA Medical Center; Stroke Division Internist, Critical Care and Geriatric Medicine; Valley Regional Hospital Stroke, Neuromuscular and General Neurology, Trillium Health Partners Mississauga; Assistant Professor at McMaster University and Lecturer at the University of Toronto. Professor of Medicine in the Division of Neurology at McMaster University; Staff Physician at Hamilton Health Sciences, Hamilton General Hospital; Senior Scientist at Population Health Research Institute United States Potential Conflicts Boehringer Ingelheim Funded researcher Potential Conflict Bristol-Myers Squibb CME events, paid speaker Potential Conflicts Bayer AG Sponsored research with personal stipend; consultancy. Bristol Myers-Squibb sponsored research with personal stipend CSBPR Sixth Edition Final 25October2017 Page 5 of 6
6 Dr. Adam Kirton Dr. Lewis B. Morgenstern Associate Professor, Pediatrics and Clinical Neurosciences, Faculty of Medicine, University of Calgary, Alberta Children s Hospital Research Institute (ACHRI), Director Calgary Pediatric Stroke Program Pediatric Associate Chair of Neurology for Faculty Development and Finance; Director of the Stroke Program; Professor of Neurology, Epidemiology, Emergency Medicine and Neurosurgery; The University of Michigan Medical School and School of Public Health Alberta United States Secondary Prevention of Stroke CCS 2016 Lipid Guidelines Michelle Slapkauskas RN BScN; Belleville General - Stroke Prevention Clinic Dr. David Spence Dr. Luciano A. Sposato Thomas Stewart MD, FRCPC Professor of Neurology and Clinical Pharmacology Director, Stroke Prevention & Atherosclerosis Research Centre (SPARC) Robarts Research Institute MD, MBA; Associate Professor of Neurology; University of Western Manager, Pre-Admission and Stroke Prevention Clinic Regina Saskatchewan Saskatchewan Potential conflicts Boehringer Ingelheim Speaker CSBPR Sixth Edition Final 25October2017 Page 6 of 6
CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS
CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Advisory and Writing Group Participants 6 th edition 2016-2018 Advisory Committee CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Stroke Best Practices Advisory
More informationWriting Group Membership
Canadian Stroke Best Practice Recommendations Writing Group Membership Updated January 2019 Heart and Stroke Foundation of Canada 2019 January 2019 P a g e 1 Overview: The Canadian Stroke Best Practice
More informationCANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Stroke Best Practices Advisory Committee
CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Stroke Best Practices Advisory Committee 2016 2018 Canadian Stroke Best Practices and Performance CSBPR Leadership Smith, Eric Co-Chair (Acute) Harrison, Ed
More informationTABLE D-1 POST-M.D. TRAINEES EXITING QUEBEC TRAINING PROGRAMS IN JULY, 2014 AT THE COMPLETION OF POST-M.D. TRAINING
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Public Health and Preventive
More informationGeographic Location, Field of Post-M.D. Training
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Public Health and Preventive
More informationGeographic Location, Field of Post-M.D. Training
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Other Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Public Health and
More informationREGISTER OF INTERESTS SIGN guideline 154: Pharmacological management of glycaemic control in people with type 2 diabetes Published: 29 November 2017
CHAIR John Petrie, Professor of Diabetic Medicine Financial Non-financial Non-personal Last updated Specific Non-Specific Specific Non- Specific Professor of Diabetic Medicine, University of Glasgow Academic.
More informationTABLE D-1 POST-M.D. TRAINEES EXITING ONTARIO TRAINING PROGRAMS IN JULY, 2013 AT THE COMPLETION OF POST-M.D. TRAINING
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Other Fam. Med. Training FAMILY MEDICINE SUBTOTAL Palliative Medicine TRAINING FOLLOWING FAMILY MEDICINE
More informationUpdate on Royal College Areas of Focused Competence (Diploma) Programs. Application Sponsor: National Body / Specialty Society
Update on Areas of Focused Competence (Diploma) AFC (Diploma) Program 1 Acute Care Point of Care Ultrasonography (Acute Care POCUS) Emergency Paediatric Emergency of Point-of-care Ultrasonography EM Fellowships
More informationPOST-M.D. TRAINEES EXITING ALBERTA TRAINING PROGRAMS IN JULY, 2015 AT THE COMPLETION OF POST-M.D
TABLE D-1 Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Public Health and Preventive Medicine Dermatology
More informationNAME CTS AFFILIATION DISCLOSURE UPDATED
NAME CTS AFFILIATION DISCLOSURE UPDATED Darcy Marciniuk (Chair) and Canadian and Canadian COPD Alliance Consultant Fee, Speaker s Bureau, Advisory Committee: AstraZeneca, Boehringer-Ingelheim, Canadian
More informationUpdate on Royal College Areas of Focused Competence (Diploma) Programs. Application Sponsor: National Body / Specialty Society
Update on Areas of Focused Competence (Diploma) AFC (Diploma) Program 1 Acute Care Point of Care Ultrasonography (Acute Care POCUS) Emergency Paediatric Emergency of Point-of-care Ultrasonography EM Fellowships
More informationPROVINCIAL LEAD AND LHIN LEADER BIOS
PROVINCIAL LEAD AND LHIN LEADER BIOS May 4, 2006 Dr. Bernard Lawless, Provincial Lead Dr. Bernard Lawless completed a residency in general surgery at the University of Western Ontario (UWO) and then did
More informationA Clinical Context Report
Stroke Prevention in Atrial Fibrillation An Expert Commentary With Kenneth W. Mahaffey, MD A Clinical Context Report Stroke Prevention in Atrial Fibrillation Expert Commentary Jointly Sponsored by: and
More informationScientific Advisory Committee Medical Devices Used in Cardiovascular Systems. Membership List and Biographies
Scientific Advisory Committee Medical Devices Used in Cardiovascular Systems Membership List and Biographies Core Members John Ducas (Chair), MD, FRCPC Renzo Cecere, MD, FRCSC, FACS Eric Cohen, MD, FRCPC
More information2016 ADHD Conference Speaker Biographies
2016 ADHD Conference Speaker Biographies Dr. Rosemary Tannock, PhD Rosemary Tannock is now Professor Emerita at the University of Toronto and continues as a Senior Scientist at the Hospital for Sick Children
More informationNATIONAL PREVENTION STRATEGY MEETING:
In Partnership with: NATIONAL PREVENTION STRATEGY MEETING: Linking research, practice and policy in the prevention of weight-related disorders. November 17 & 18, 2011 Location: The Metropolitan Hotel 108
More informationNATIONAL SYNERGISTIC CORE RESOURCES. Kidney REsearch Scientist Core Education and National Training program (KRESCENT)
Strategy for Patient-Oriented Research Putting Patients First VISION Can-SOLVE CKD Network Vision: By 2020, every Canadian with, or at high risk for, chronic kidney (CKD) will receive the best recommended
More informationUpdate on Royal College Areas of Focused Competence (Diploma) Programs. Application Sponsor: National Body / Specialty Society
Update on Areas of Focused Competence (Diploma) AFC (Diploma) Program 1 Acute Care Point of Care Ultrasonography (Acute Care POCUS) Emergency Medicine Paediatric Emergency Medicine Canadian of Point-of-care
More informationENDOCRINOLOGY/METABOLISM PROFILE
ENDOCRINOLOGY/METABOLISM PROFILE GENERAL INFORMATION (Source: Pathway Evaluation Program, Royal College of Physicians and Surgeons, The Hormone Foundation) Endocrinology and Metabolism is the branch of
More informationData sharing in Canada through the COGR:
Data sharing in Canada through the COGR: a unified clinical genome database as a community resource for standardizing and sharing genetic interpretations Dr. Matthew Lebo, Kathleen-Rose Zakoor, Dr. Jordan
More informationNATIONAL PALLIATIVE MEDICINE SURVEY QUESTIONNAIRE
NATIONAL PALLIATIVE MEDICINE SURVEY QUESTIONNAIRE Canadian Society of Palliative Care Physicians Canadian Medical Association College of Family Physicians of Canada Royal College of Physicians and Surgeons
More informationImproving access to oral health care for vulnerable people living in Canada. A Canadian Academy of Health Sciences Report
Improving access to oral health care for vulnerable people living in Canada A Canadian Academy of Health Sciences Report Acknowledgements Sponsors: Association of Canadian Faculties of Dentistry Canadian
More informationCanadian Antiplatelet Therapy Guidelines: 2014 Update James D. Douketis MD, FRCP(C)
Canadian Antiplatelet Therapy Guidelines: 2014 Update James D. Douketis MD, FRCP(C) Department of Medicine, St. Joseph s Healthcare Hamilton and McMaster University, Hamilton, Canada Disclosures for: James
More informationUpdate on the Stroke Capacity Planning Project. January 09, 2015
Update on the Stroke Capacity Planning Project January 09, 2015 Today s discussion Objective : Provide an update on the Ministry of Health and Long Term Care Stroke Capacity Planning and alignment with
More informationALBERTA PRINCIPAL INVESTIGATORS
ALBERTA PRINCIPAL INVESTIGATORS Dr. Gregory Cairncross is Head of the Department of Clinical Neurosciences at the University of Calgary and holder of the Alberta Cancer Foundation Chair in Brain Tumor
More informationDERMATOLOGY PROFILE GENERAL INFORMATION
DERMATOLOGY PROFILE GENERAL INFORMATION (Sources: the Canadian Medical Residency Guide and Pathway Evaluation Program, Royal College) Dermatology is a diverse specialty that deals with benign and malignant
More informationObjectives. Mood and Cognition for Stroke Writing Group Members
Dr. Gail Eskes Department of Psychiatry Dalhousie University Chair, Writing Group for Mood and Cognition Post Stroke 2 Objectives Become familiar with the 2013 updates to the recommendations for the management
More informationSTEMI Care 2014 at the Crossroads: Taking the right road
STEMI Care 2014 at the Crossroads: Taking the right road Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Vice President, The Canadian Association of Interventional Cardiology Director,
More informationGERIATRIC MEDICINE PROFILE
GERIATRIC MEDICINE PROFILE Geriatric Medicine deals with the prevention, diagnosis, treatment, remedial and social aspects of illness in older people, mainly patients 75 years of age or more. Most certified
More informationP R O G R A M. ONTARIO ORTHOPAEDIC ASSOCIATION 38 th ANNUAL GENERAL MEETING. Orthopaedic Surgery in 2015: Limited or Limitless? October 30 31, 2015
P R O G R A M ONTARIO ORTHOPAEDIC ASSOCIATION 38 th ANNUAL GENERAL MEETING Orthopaedic Surgery in 2015: Limited or Limitless? October 30 31, 2015 Hyatt Regency Toronto 370 King Street West, Toronto 416
More informationGil Kaplan, MD, MPH, FRCPC. Eric Benchimol, MD, PhD, FRCPC
Gil Kaplan, MD, MPH, FRCPC Co-Chair, 2018 CCC Impact of IBD Report CIHR Embedded Clinician Research Chair University of Calgary Eric Benchimol, MD, PhD, FRCPC Co-Chair, 2018 CCC Impact of IBD Report Associate
More informationMembership of cirrhosis guideline Committee
Membership of cirrhosis guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on cirrhosis. The terms of reference and standing orders for the
More informationPRESENTATION TO THE STANDING COMMITTEE ON HEALTH Post-Market Surveillance of Pharmaceutical Products March 11, 2008
Cancer Advocacy Coalition 60 St. Clair Ave. East, Suite 204 Toronto, Ontario M4T 1N5 Tel: (416) 538-4874 Toll Free: 1 877 472-3436 canceradvocacy@on.aibn.com www.canceradvocacy.ca PRESENTATION TO THE STANDING
More informationSimilar risk of malignancy with insulin glargine and neutral protamine Hagedorn
Letter Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, openlabel study J. Rosenstock 1,2,
More informationOTOLARYNGOLOGY PROFILE
OTOLARYNGOLOGY PROFILE Otolaryngology is concerned with the screening, diagnosis and management of medical and surgical disorders of the ear, the upper respiratory and upper alimentary systems, and related
More informationigh-sensitivity Cardiac Troponin - A Canadian Viewpoint from CIHR funded studies Friday May 30, 2014
8:50-9:00 Welcome and Introduction Juravinski Cancer Center Lecture Theatre (4 th floor) 699 Concession St. Hamilton, ON L8V 5C2 Introduction to High-Sensitivity Cardiac Troponin Current State 9:00-9:45
More informationCAHS report on access to oral health care: strategic pressure for change. A Presentation for Public Health Ontario August 2015
CAHS report on access to oral health care: strategic pressure for change A Presentation for Public Health Ontario August 2015 Presentation outline Background brief overview of CAHS report Focus of presentation
More informationJournal of the American College of Cardiology
Advertisement Journal of the American College of Cardiology Volume 72, Issue 3, July 2018 DOI: 10.1016/j.jacc.2018.04.063 PDF Article Download Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory
More informationOverview Stroke Post Acute Episode of Care
Overview Stroke Post Acute Episode of Care Dr. Mark Bayley Dr. Leanne Casaubon OSN Forum January 9, 2015 Key Principles The scope of the handbook includes both hospital care and post acute, community care
More informationNational, volunteer-based charity focused on finding the cures for Crohn s Crohn's and Colitis Canada
Table 1 Diabetes organisations and groups used for recruitment Support groups and organization About the organization Alberta Children's Hospital & transition clinics Children's hospital in Calgary British
More informationThe 16th Annual Geriatric Services Conference DRAFT PROGRAM
GERIATRIC SERVICES CONFERENCE The 16th Annual Geriatric Services Conference DRAFT PROGRAM CONNECT. COLLABORATE. CREATE. Friday, April 12, 2019 Vancouver Convention Centre The 16th Annual Geriatric Services
More informationSunday, May 7, :00 PM 6:30 PM Buffet; 6:30 PM 8:00 PM Presentation Sheraton Grand, Chicago Ballroom 8-10
Sunday, May 7, 2017 6:00 PM 6:30 PM Buffet; 6:30 PM 8:00 PM Presentation Sheraton Grand, Chicago Ballroom 8-10 www.cmeoutftters.com/uccase17 Provided by This program is not affiliated with Digestive Disease
More informationMichelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier
Michelle Greiver Simone Dahrouge Patricia O Brien Donna Manca Marie-Thérèse Lussier University of Toronto Practice Based Research Network Ottawa Practice Enhancement Network Quality & Innovation Program,
More informationChanging Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
Saturday, October 27, 2018 7:00 AM - 3:45 PM Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer Program Director John V.
More informationA.K. Gitt, F. Towae, C. Juenger, A. Papp, R. Zahn, U. Zeymer, J. Senges For the STAR-Study-Group Herzzentrum Ludwigshafen, Germany
Impact of Interventional Versus Conservative Approach on 5-Year-Mortality of Patients With Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry A.K. Gitt,
More informationPublic Health Guidelines for Sedentary Behaviour
Public Health Guidelines for Sedentary Behaviour Mark Tremblay, Ph.D., D.Litt. (hons), FACSM, CSEP-CEP Director, Healthy Active Living and Obesity Research Group Children s Hospital of Eastern Ontario
More informationEstimating organ donor potential: a comparable tool to track performance, identify gaps and help save lives
Estimating organ donor potential: a comparable tool to track performance, identify gaps and help save lives Presented by: Christina Lawand, Senior Researcher Sheril Perry, Project Lead Health System Analysis
More informationPatient-Centred Research Priorities Relating to Healthcare of Frail Older Canadians
Patient-Centred Research Priorities Relating to Healthcare of Frail Older Canadians Canadian Frailty Network Annual National Conference April 24, 2017 Jennifer Bethell, Martine Puts, Katherine McGilton,
More informationDr. K. Briar Sexton Curriculum Vitae
Dr. K. Briar Sexton Curriculum Vitae General & Neuro-Ophthalmology Clinical Assistant Professor, Department of Ophthalmology University of British Columbia 4-1854 West 1 st Avenue, Vancouver, BC, V6J1G5
More informationFRIDAY DECEMBER 8, 2017
FRIDAY DECEMBER 8, 2017 8:20-9:05 Keynote Address - Genetics of Stroke: Getting Up Close and Personal Guillaume Paré MD, MSc, FRCPC Associate Professor, McMaster University Canada Research Chair in Genetic
More informationThis article is a CME/CE certified activity. To earn credit for this activity visit:
Novel Perspectives on Type 2 Diabetes: Traditional and Emerging Therapies and the Potential Role of the Kidneys This article is a CME/CE certified activity. To earn credit for this activity visit: www.medscape.org/lecture/t2dm-therapies
More informationWHICH ANTITHROMBOTIC REGIMEN? Action Study Group Institut de Cardiologie - Pitié-Salpêtrière Hospital Paris, France.
TAVI WITH ATRIAL FIBRILLATION: WHICH ANTITHROMBOTIC REGIMEN? G. MONTALESCOT (PARIS, FR) Action Study Group Institut de Cardiologie - Pitié-Salpêtrière Hospital Paris, France www.action-cœur.org Dr. Montalescot
More informationRising Tide: The Impact of Dementia in Canada 2008 to 2038 October 2009
Rising Tide: The Impact of Dementia in Canada 2008 to 2038 October 2009 North York Corporate Centre 4576 Yonge Street, Suite 400 Toronto, ON M2N 6N4 Tel: (416) 782 7475 Fax: (416) 309 2336 www.riskanalytica.com
More informationThe 16th Annual Geriatric Services Conference PROGRAM
GERIATRIC SERVICES CONFERENCE The 16th Annual Geriatric Services Conference PROGRAM CONNECT. COLLABORATE. CREATE. Friday, April 12, 2019 Vancouver Convention Centre The 16th Annual Geriatric Services Conference
More informationSecondary stroke prevention services in Canada: a cross-sectional survey and geospatial analysis of resources, capacity and geographic access
Secondary stroke prevention services in Canada: a cross-sectional survey and geospatial analysis of resources, capacity and geographic access Lauren Jewett BSc MGIS, Adil Harroud MD, Michael D. Hill MD
More informationThe 16th Annual Geriatric Services Conference DRAFT PROGRAM
GERIATRIC SERVICES CONFERENCE The 16th Annual Geriatric Services Conference DRAFT PROGRAM CONNECT. COLLABORATE. CREATE. Friday, April 12, 2019 Vancouver Convention Centre The 16th Annual Geriatric Services
More informationHealth Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods
ENVIRONMENTAL SCAN Health Interventions in Ambulatory Cancer Care Centres Context Cancer, a complex, chronic condition, will affect an estimated two in five Canadians in their lifetime. 1 Cancer requires
More informationEchocardiography. The Tenth Annual CANADIAN ECHO WEEKEND. Educational Symposium of the. Canadian Society of Echocardiography
Canadian Society of Echocardiography The Tenth Annual CANADIAN ECHO WEEKEND Educational Symposium of the Canadian Society of Echocardiography Thursday April 24 th, to Saturday April 26 th, 2008 Vancouver
More informationCritical Care Medicine. Critical Care Medicine Profile
Updated March 2018 Click on any of the contents below to navigate to the slide. Please click the home icon located at the top right of each slide to return to the table of contents slide. TABLE OF CONTENTS
More informationABOUT ADVANCES IN STROKE RECOVERY REGISTRATION
ABOUT ADVANCES IN STROKE RECOVERY Advances in Stroke Recovery is an annual meeting showcasing exciting new discoveries and research in stroke recovery. This year, the Heart and Stroke Foundation Canadian
More information18:30 Meeting with facilitators/chairs at Best Western Parkway Hotel 19:00 Cocktail reception for all meeting
Thursday, December 4, 2014 18:30 Meeting with facilitators/chairs at Best Western Parkway Hotel 19:00 Cocktail reception for all meeting Friday, December 5, 2014 8:45 8:55 am Overview of the agenda André
More informationThe HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study
The HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study Apostolakis S 1, Lane DA 1, Buller H 2, Lip GY 1 1 University
More informationChicago, USA June 28-30, 2018 THE SYMPOSIUM PREVENTING CARDIOEMBOLIC STROKE AS AN INTERDISCIPLINARY TEAM. hbs.kenes.com
Chicago, USA June 28-30, 2018 THE SYMPOSIUM PREVENTING CARDIOEMBOLIC STROKE AS AN INTERDISCIPLINARY TEAM hbs.kenes.com The Heart & Brain Symposium offers a comprehensive guide to primary and secondary
More informationCSHT 2014 Conference Presenter Biographies
CSHT 2014 Conference Presenter Biographies Shrikant J. Chinchalkar, M.Th.O, BSc OT, OTR, CHT Hand and Upper Limb Centre, St. Joseph s Health Centre, London, Ontario. Shrikant J. Chinchalkar is a hand therapist
More informationTRANSIENT ISCHEMIC ATTACK (TIA)
TRANSIENT ISCHEMIC ATTACK (TIA) AND MINOR STROKE Dr. Leanne K. Casaubon, MD MSc FRCPC Associate Professor, University of Toronto Director, TIA and Minor Stroke (TAMS) Unit University Health Network - Toronto
More informationQuarter Performance Report
Canadian Cancer Clinical Trials Network Quarter Performance Report Quarter 07/8: April June 30, 07 Report Created: Sept 8, 07 Table of Contents Section A: Progress at Adult Network Sites... Section B:
More informationCanadian Pediatric Anesthesia Research Network HIGHLIGHTS: Launch Meeting, November 5, 2009
Canadian Pediatric Anesthesia Research Network HIGHLIGHTS: Launch Meeting, November 5, 2009 OVERVIEW With the support of an MICYRN Seed Grant, 13 pediatric anesthesiology team members met in Toronto on
More informationFaculty. Course Directors. Liza Blumenfeld, MA, CCC-SLP, BCS-S UC San Diego Health - Speech-Language Pathologist
Faculty Course Directors Liza Blumenfeld, MA, CCC-SLP, BCS-S UC San Diego Health - Speech-Language Pathologist Non-financial Disclosure: Developer of Swallow RehApp Joseph Califano, MD UC San Diego Health
More informationAppendix K Declarations of Interests
Appendix K Declarations of Interests Ms Theresa Shaw - Chair, Guideline Development Group Chief Executive, Foundation of Nursing Studies (FoNS), London Funding for the 'Developing Practice for Healthy
More informationTECHNOLOGY OVERVIEW: PHARMACEUTICALS
TECHNOLOGY OVERVIEW: PHARMACEUTICALS ISSUE 8.0 OCTOBER 1997 MACROLIDES IN COMMUNITY-ACQUIRED PNEUMONIA AND OTITIS MEDIA based primarily on the Technical Report: A Therapeutic and Economic Evaluation of
More informationCHAPTER 3 Hyperacute Stroke Care
CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE Fourth Edition Lindsay MP, Gubitz G, Bayley M, Phillips S (Editors), on Behalf of the Canadian Stroke Best Practices and Standards Working Group CHAPTER
More informationPRACTICAL MANAGEMENT OF NOAC s December 8,
PRACTICAL MANAGEMENT OF NOAC s December 8, 2017 1 Faculty Disclosure Faculty: John Eikelboom MBBS, MSc, FRCPC Jack Hirsh/PHRI Chair in Thrombosis and Atherosclerosis Career Award, Heart and Stroke Foundation
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
More informationOrganizational, or Other Financial Benefit None None None None None None. None None None None None None
Comprehensive Relationships With Industry and Other Entities AHA/ACC 2017 Update of ST-Elevation Myocardial Infarction and Non ST-Elevation Myocardial Infarction Measures Committee Jneid Hani, Chair Baylor
More informationcredo: Why, What and How Laura Lee Hall, Ph.D. Associate Director, Strategic Educational Initiatives American College of Cardiology
credo: Why, What and How Laura Lee Hall, Ph.D. Associate Director, Strategic Educational Initiatives American College of Cardiology National Minority Quality Forum Washington, DC April 19 th, 2010 Disclosures
More informationCANADIAN STROKE BEST PRACTICE RECOMMENDATIONS
\\ CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS Advisory Committee Members and Writing Group Participants 5 th edition 2013-2015 Page 1 Included below is a list of the Stroke Best Practices and Quality
More informationAbout the Canadian Stroke Congress
1 About the Canadian Stroke Congress The Canadian Stroke Congress, a joint initiative of the Heart and Stroke Foundation and the Canadian Stroke Consortium, is the premier meeting in Canada for researchers,
More informationAvoiding diagnostic error by understanding how physicians think. Patrick Croskerry PLENARY SESSION 9:00 10:00 SPEAKER PROFILE
PLENARY SESSION 9:00 10:00 Patrick Croskerry MD, PhD, FRCP(Edin) Professor and Director, Critical Thinking Program, Division of Medical Education, Dalhousie University Dr. Patrick Croskerry is a professor
More informationWest Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 24, 2016 (Week 38)
West Nile Virus and Other Mosquito-borne Diseases National Surveillance Report English Edition September 18 to September 4, 16 (Week 38) Canada Humans During surveillance week 38, ending on September 4,
More informationCYSTIC FIBROSIS CANADA S CF PHYSICIAN PANEL ON LUMACAFTOR/IVACAFTOR: RECOMMENDATIONS FOR CRITERIA FOR CLINICAL USE
CYSTIC FIBROSIS CANADA S CF PHYSICIAN PANEL ON LUMACAFTOR/IVACAFTOR: RECOMMENDATIONS FOR CRITERIA FOR CLINICAL USE I - INTRODUCTION a) Cystic Fibrosis Cystic fibrosis (CF) is the most common fatal genetic
More informationHot Topics in Neurology
Hot Topics in Neurology A CME Conference designated for 5.0 AMA PRA Category I Credits and 5.0 ABIM MOC points Friday, March 3, 2017 7:30am 2:00pm Northwell Health Corporate Administration Building 2000
More informationORTHOPEDIC SURGERY PROFILE
ORTHOPEDIC SURGERY PROFILE Orthopedic surgery focuses on the diagnosis, treatment, rehabilitation and prevention of diseases of the bones, joints, ligament, muscles, tendons and nerves. These specialists
More informationCanadian Interventional Pain Course
15.0 MAINPRO M1 MOC SECTION 1 CIPC 2016: Canadian Interventional Pain Course Burning Questions in Interventional Pain Management APR 1-2, 2016 FRI-SAT APR 1: THE SUTTON PLACE HOTEL APR 2: UBC LIFE SCIENCES
More informationPAUL GROF CURRICULUM VITAE. Mood Disorders Center Russell Rd. Smyth Medical Center Ottawa, ON, Canada K1G 4G3 and
1 Archives (Grof Collection) June 23, 2016 PAUL GROF CURRICULUM VITAE OFFICES Mood Disorders Center 202-1929 Russell Rd. Smyth Medical Center Ottawa, ON, Canada K1G 4G3 and Mood and Anxiety Disorders Program
More informationMeet some of our experts
WELCOME TO MEDISYS Meet some of our experts Our national team of healthcare professionals comprise some of Canada s foremost leaders in preventive health, travel health, nutrition, fitness, and disease
More informationPHYSICAL MEDICINE & REHABILITATION
PHYSICAL MEDICINE & REHABILITATION () INTRODUCTION The consultant in Physical Medicine and Rehabilitation (or physiatrist) is a medical specialist expert in the comprehensive diagnosis, management and
More informationDo Clinical Practice Guidelines Improve Outcomes?
Do Clinical Practice Guidelines Improve Outcomes? Canadian Cardiovascular HArmonization of National Guidelines Endeavour James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of
More informationWhy is Earlier and More Aggressive Treatment of T2 Diabetes Better?
Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:
More informationTrue cryptogenic stroke
True cryptogenic stroke Arne Lindgren, MD, PhD Dept of Clinical Sciences Lund, Neurology, Lund University Dept of Neurology and Rehabilitation Medicine Skåne University Hospital Lund, Sweden Disclosures
More informationGeneral Internal Medicine. General Internal Medicine Profile
Updated March 2018 1 Click on any of the contents below to navigate to the slide. Please click the home icon located at the top right of each slide to return to the table of contents slide. TABLE OF CONTENTS
More informationIsrael Makov President and Chief Executive Officer Teva
Israel Makov President and Chief Executive Officer Israel Makov has been the President and Chief Executive Officer of since April 2002. Previously he served as 's Chief Operating Officer from January 1,
More informationAlpha One Anti-Trypsin Deficiency: Challenges in Diagnosis and Treatment Final Outcome Report
Challenges in Pulmonary and Critical Care: 2016 Alpha One Anti-Trypsin Deficiency: Challenges in Diagnosis and Treatment Final Outcome Report Report Date: March 2, 2017 Course Director Franck Rahaghi,
More information2017 Opioid Guideline Update
2017 Opioid Guideline Update The 2017 Canadian Guideline for Opioid Therapy and Chronic Non-Cancer Pain (CNCP) Dr. Lydia Hatcher, MD, CCFP, FCFP, CHE, D-CAPM Associate Clinical Professor of Family Medicine,
More informationAntithrombotic therapy in the ACS patient with atrial fibrillation
Antithrombotic therapy in the ACS patient with atrial fibrillation Kurt Huber, MD, FESC, FACC, FAHA 3 rd Medical Department Cardiology & Emergency Medicine Wilhelminenhospital Vienna, Austria Great Minds,
More informationAFATINIB FOLLOWED BY OSIMERTINIB IN REAL-WORLD PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC: AN OBSERVATIONAL STUDY
AFATINIB FOLLOWED BY OSIMERTINIB IN REAL-WORLD PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC: AN OBSERVATIONAL STUDY Maximilian J. Hochmair, 1 Alessandro Morabito, 2 Desiree Hao, 3 Cheng-Ta Yang, 4 Ross A.
More informationCRS 2014 Chapter Report Chicago Canada Chapter
Chapter Name: Canadian Chapter of the Controlled Release Society (CC-CRS) Date Established: 2009 Board of Directors (list names and positions): President: Todd Hoare McMaster University Department of Chemical
More informationJohn Ansell President, John Ansell Consultancy Thame, UK
Rutgers University Monday 29 September 2014 Co Eli Lilly Bristol-Myers Squibb Novo Nordisk Pfizer GlaxoSmithKline Takeda Sanofi Novartis AstraZeneca Roche Otsuka Johnson & Johnson Otsuka Abbott Teva 1
More informationTask Force Members: Mandy Lauw, Chairman Geoff Barnes, Immediate Past Chairman
Task Force Members: Mandy Lauw, Chairman Mandy Lauw (30, The Netherlands) is a Research Fellow at the Departments of Vascular Medicine and Hematology, Academic Medical Center, Amsterdam, The Netherlands,
More informationSUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD
SUMMARY OF CURRICULUM VITAE LUIS SOUHAMI, MD PERSONAL INFORMATION Date of birth: February 22, 1949 Marital status: Married, 2 children Place of birth: Vitoria, Brazil Citizenship: Brazilian, Canadian WORK
More information